Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR ...

A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...

Image of the Versius Surgical System Image of the Versius Surgical System being used during a simulation of a cholecystectomy (Photo: CMR Surgical) A single bedside unit of the Versius Surgical System ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical will demonstrate at SRS 2026, for the first time to a surgical audience, the potential for Versius Plus™ to leverage surgical data to help predict how a procedure may unfold. Built on ...

Following the FDA clearance of its Versius robot last fall, CMR Surgical has posted another major funding round, raising more than $200 million to bolster its U.S. commercial launch. The financing ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR Surgical said Tuesday it received 510(k) clearance from the Food and Drug Administration for its next-generation robotic ...

Less than eight months after getting FDA's blessing to bring its Versius surgical robotic system to the U.S. market, Cambridge, England-based CMR Surgical is reportedly seeking a buyer. The Financial ...

Surgical robotics company CMR Surgical – the global surgical robotics company – announced the closing of a financing round of over $200 million through a combination of equity and debt capital to ...

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, priming the company to go ahead with US commercialisation ...